{"organizations": [], "uuid": "fd45fd1cfdf90855fd6f84bf007eed10927f180e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/6", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/28/globe-newswire-trevena-to-host-conference-call-on-march-7th-to-discuss-full-year-2017-financial-results.html", "country": "US", "domain_rank": 767, "title": "Trevena to Host Conference Call on March 7th to Discuss Full Year Financial Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T15:00:00.000+02:00", "replies_count": 0, "uuid": "fd45fd1cfdf90855fd6f84bf007eed10927f180e"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/28/globe-newswire-trevena-to-host-conference-call-on-march-7th-to-discuss-full-year-2017-financial-results.html", "ord_in_thread": 0, "title": "Trevena to Host Conference Call on March 7th to Discuss Full Year Financial Results", "locations": [], "entities": {"persons": [{"name": "trevena", "sentiment": "negative"}], "locations": [{"name": "pa.", "sentiment": "none"}, {"name": "chesterbrook", "sentiment": "none"}], "organizations": [{"name": "trevena, inc.", "sentiment": "neutral"}, {"name": "trevena trevena, inc.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the quarter and year ended December 31, 2017 and to discuss recent corporate highlights.\nTo join the call, please dial-in at (855) 465-0180 (conference ID: 7843918).\nTo join a live audio webcast of the call, please visit the Investor Presentation section of the Company’s website (conference ID: 7843918). Following the conclusion of the call, the webcast will be available for replay for 30 days.\nAbout Trevena\nTrevena, Inc. is a biopharmaceutical company focused on providing better, safer therapies to patients in pain. The Company has leveraged breakthrough science to discover and develop its investigational product OLINVO™ (oliceridine) Injection for the management of moderate-to-severe acute pain. The Company also has an early stage pipeline of new chemical entities targeting novel mechanisms of action, including for acute migraine, neuropathic pain, and other indications.\nContacts\nTrevena, Inc.\nInvestors:\nJonathan Violin, Ph.D.\nSVP, scientific affairs and investor relations officer\n610-354-8840 x231\njviolin@trevena.com\nor\nMedia:\nPublic Relations\nPR@trevena.com\nSource:Trevena Inc.", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/ae169b46-44f6-4579-8e3f-4e54196e55bb", "https://www.globenewswire.com/Tracker?data=5f3dMdRnXMrnWlaA3CnEtzdup_S1PRqTrYVU9drGvokoCLyH2Pmp0fgS_vpvwpXfEoIRz4BCArvhMuxy-bBGObnPFX23tTBvFT6bMxJnX1rx-AooT2isgPDOU6-5rbeN", "https://www.globenewswire.com/Tracker?data=eq-t3YyyLa7EG2iCOw3bt8kNUIxyBZBSpH9YrYuhaQAOSoG0IqybA0hYelIkJzPm_y0-dgEOIVFK7aR9tthkq3-mPYugIs6tEzp4Ho7Kgp0="], "published": "2018-02-28T15:00:00.000+02:00", "crawled": "2018-02-28T17:12:25.021+02:00", "highlightTitle": ""}